Product Information
LIDOCAINE 4% CREAM is a generic product labeled by Oncor Pharmaceuticals, priced at $0.4899 per GM under NDC 83720052301. Its NADAC has been published 117 times since Jul 10, 2024.
Strength
4 g/100g
Manufacturer
Oncor PharmaceuticalsNDC
83720052301
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M017On Market Since
5/22/2024
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 4% CREAM has been published 117 times since Jul 10, 2024, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4899 per GM |
|---|---|
| All-time high | $0.5579 (Sep 11, 2024) |
| All-time low | $0.4094 (Nov 20, 2024) |
| 52-week high | $0.5401 |
| 52-week low | $0.4444 |
| Median price | $0.4859 |
| Average price | $0.4855 |
| Largest weekly change | -21.4% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oncor Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine 4% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 4% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 4% CREAM, manufactured by Oncor Pharmaceuticals, is $0.4899 per GM (NDC 83720052301), effective Sep 30, 2026.
How has the price of LIDOCAINE 4% CREAM changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 4% CREAM has risen 3.5%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 4% CREAM?
Since Jul 10, 2024, the NADAC for LIDOCAINE 4% CREAM has ranged from a low of $0.4094 (Nov 20, 2024) to a high of $0.5579 (Sep 11, 2024), with a median of $0.4859 per GM.
Are there cheaper alternatives to LIDOCAINE 4% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE 4% CREAM, is $0.4276 per GM — about 13% below LIDOCAINE 4% CREAM.
Who manufactures LIDOCAINE 4% CREAM?
LIDOCAINE 4% CREAM (NDC 83720052301) is labeled by Oncor Pharmaceuticals, and CMS classifies it as a generic product.